Streetbeat News

Products Services

DFLI

Dragonfly Energy has partnered with Meyer Distributing to expand the reach of its Battle Born Batteries into new markets. This strategic partnership aims to leverage Meyer Distributing's extensive distribution network to drive sales and market penetration for Dragonfly Energy's products.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:12 am

RGNX

Regenxbio has concluded a pre-biologics license application (BLA) meeting with the FDA for its RGX-121 treatment for Mucopolysaccharidosis Type II. The company plans to initiate a rolling BLA submission in Q3 2024, with a confirmatory trial expected to begin in H2 2025. The FDA has confirmed that the commercial bulk drug is comparable to the clinical material.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:11 am

CLNN

Clene presented new long-term results for its CNM-Au8 treatment at the European Network for the Cure of ALS meeting, showing improved survival and reduced neurofilament light levels in ALS patients.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:09 am

IONS

Otsuka Pharmaceutical has obtained exclusive rights across the Asia-Pacific region for Ionis Pharmaceuticals' donidalorsen for hereditary angioedema. Ionis will receive a $20M upfront payment and milestone payments. Ionis will handle primary development, while Otsuka will manage territory-specific development, regulatory filings, and commercialization in the Asia-Pacific region and Europe.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:06 am

LQDT

Liquidity Services has partnered with Aaron Industrial Solutions and Binswanger to sell a turnkey medical device manufacturing plant. This collaboration aims to leverage the expertise of all three companies to maximize the value of the sale.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:51 am

TSLA

Tesla Inc (NASDAQ:TSLA) announced that its Model 3 Long Range variant now qualifies for a $7,500 federal tax credit, making it only $1,000 more expensive than the cheapest variant. The Performance version also qualifies for the tax credit, while the cheapest rear-wheel drive Model 3 does not. All versions of the Model Y SUV and the Long Range variant of the Model X are also eligible for the tax credit. This move is expected to boost EV adoption by lowering the final purchase price for customers.

Portfolio Pulse from Anan Ashraf

June 18, 2024 | 10:50 am

GOOG

GOOGL

Google's AI assistant, Gemini, is launching its mobile app in India, supporting English and nine regional languages. This move aims to cater to India's diverse linguistic landscape and mobile-first approach. The app offers new features like data analysis, file uploads, and integration with Google Messages.

Portfolio Pulse from Ananthu C U

June 18, 2024 | 10:39 am

KALV

KalVista Pharmaceuticals has submitted a New Drug Application (NDA) to the FDA for Sebetralstat, an oral plasma kallikrein inhibitor for treating hereditary angioedema (HAE) attacks. The FDA will review the NDA within 60 days, with a decision expected in September. KalVista plans to seek additional marketing authorizations globally in 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:32 am

CALT

Calliditas Therapeutics has received a patent for NOX inhibitors, which are intended for the treatment of cancer. This development could potentially enhance their product portfolio and market position in the oncology sector.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:27 am

SQNS

Sequans has decided to optimize its R&D expenses by suspending the development of its 5G fixed wireless product. The company will now focus on low-power 5G technology for massive IoT applications.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:26 am